Products

S.NO	API	CAS NO	THERAPEUTIC USE	pharmacopoeia	Docs Available
1	Ezetimibe	163222-33-1	Anti-hyperlipidaemic	IP/USP	DMF, WHO GMP, WC
2	Dorzolamide Hydrochloride	130693-82-2	Glaucoma	IP/EP/USP	CEP, DMF, WC, WHO GMP
3	Bilastine	202189-78-4	Anti-Histamine	IH/IP	DMF, WHO GMP, WC
4	Rivaroxaban	366789-02-8	Anticoagulant	IP/EP/USP	Under Development
5	Suvorexant	1030377-33-3	Insomnia	IH	DMF, WHO GMP, WC
6	Bempedoic Acid	738606-46-7	Lipid Lowering Agent	IH	Under Development

S.NO	INTERMEDIATE NAME	CAS NO	Code	STATUS
EZETIMIBE
1	(S)-(+)-4-Phenyl-2-oxazolidinone	99395-88-7	SPOZ	Reagent & commercialized
2	(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone	189028-93-1	EZE-2	Intermediate & commercialized
3	4-[[(4-Fluorophenyl) imino]methyl]-phenol	3382-63-6	EZE-S2	Key starting material & commercialized
4	(4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one	1185883-40-2	EZE-5	Intermediate & commercialized
5	(S)-3-((2R,5S)-5-(4-fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl) oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one	272778-12-8	EZT-4	Intermediate & commercialized
DORZOLAMIDE HYDROCHLORIDE
6	(3S)-3-(2-Thienylthio) butanoic acid	133359-80-5	DOR-H1	Advanced Key starting material & commercialized (100% Indigenous)
7	(6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b] thiopyran-4-one	148719-91-9	DOR-2	Key starting material & commercialized (100% Indigenous)
8	(4R,6S)-5,6-Dihydro-4-hydroxy-6-methylthieno [2,3-b] thiopyran-7,7-dioxide	147128-77-6	DOZ-S1	Key starting material & commercialized (100% Indigenous)
9	N-[(4S,6S)-6-Methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b] thiopyran-4-yl] acetamide	147086-83-7	DOZ-1	Advanced Intermediate & commercialized (100% Indigenous)
10	N-[(4S,6S)-2-(Aminosulfonyl)-5,6-dihydro-6-methyl-7,7-dioxido-4H-thieno[2,3-b] thiopyran-4-yl] acetamide	147200-03-1	DOZ-4	Advanced Intermediate & commercialized (100% Indigenous)
BILASTINE
11	Methyl-2-(4-(2-chloroethyl)phenyl-2-methylpropanoate	1181267-33-3	BIL-S1	Key starting material & commercialized (100% Indigenous)
12	1-(2-Ethoxyethyl)2-(piperidin-4-yl)1H-benzo[d]imidazole hydrochloride	1841081-72-8	BIL-S2	Key starting material & commercialized (100% Indigenous)
13	Methyl2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl) piperidin-1-yl) ethyl) phenyl)-2-methylpropanoate (Bilastine Ester)	1181267-38-8	BIL-Ester	Advanced Intermediate & commercialized (100% Indigenous)
RIVAROXABAN
14	4-(4-Aminophenyl) morpholin-3-one	438056-69-0	RIV-S1	Key starting material & commercialized (100% Indigenous)
15	(S)-(+)-N-(2,3-Epoxypropyl)phthalimide	161596-47-0	RIV-S2	Key starting material & commercialized (100% Indigenous)
16	5-Chlorothiophene-2-carboxylic acid	24065-33-6	RIV-S3	Key starting material & commercialized (100% Indigenous)
17	2-[(2R)-2-Hydroxy-3-{[4-(3-oxomorpholin-4-yl)phenyl]amino}propyl]-1H-isoindole-1,3(2H)-dione	446292-07-5	RIV-1	Advanced Intermediate & Commercialized (100% Indigenous)
18	2-{(2R)-2-hydroxy-3-[4-(3-oxomorpholin-4-yl)anilino]propyl}-1H-isoindole-1,3(2H)-dione	446292-08-6	RIV-2	Advanced Intermediate & Commercialized (100% Indigenous)
19	4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride	898543-06-1	RIV-3	Advanced Intermediate & Commercialized (100% Indigenous)
SUVOREXANT
20	5-chloro-1,3-benzoxazole-2-thiol	22876-19-3	DBX-I	Advanced Intermediate & Commercialized (100% Indigenous)
21	(R)-Benzyl-5-methyl-1,4-diazepane-1-carboxylate	1001401-60-0	SUV-S1	Advanced Intermediate (100% Indigenous)
22	5-Methyl-2-(2H-1,2,3-triazole-2-yl) benzoic acid	956317-36-5	SUV-S2	Advanced Intermediate (100% Indigenous)
23	2,5-Dichloro-1,3-Benzoxazole	3621-81-6	SUV-S3	Advanced Intermediate & Commercialized (100% Indigenous)
24	Benzyl (5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepane-1-carboxylate	1030377-31-1	SUV-1	Commercialized (100% Indigenous)
25	(7R)-7-Methyl-1-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepane	1030377-32-2	SUV-2	Advanced Intermediate & Commercialized (100% Indigenous)
BOSENTAN
26	Dimethyl-2-chloromalonate	28868-76-0	2-CDM	Key starting material & commercialized (100% Indigenous)
CHIRAL RESOLVING AGENT
27	R-(-)-N-(3,5-Dinitrobenzoyl)-α-Phenylglycine	74927-72-3	DPG	Advanced Intermediate & Commercialized (100% Indigenous)
ALOGLIPTIN/LINGLIPTIN/TRELAGLIPTIN
28	(R)-3-Aminopiperidine Dihydrochloride	334618-23-4	APD	Advanced Intermediate & Commercialized (100% Indigenous)
CINACALCET HYDROCHLORIDE
29	1-(1-Naphthelen-1-yl)ethaneamine	3886-70-2	NEA	Key starting material for cinacalcet HCl & commercialized (100% Indigenous)
BEMPEDOIC ACID
30	Ethyl 7-bromo-2,2-dimethylheptanoate	123469-92-1	BEM-S1	Advanced Intermediate for Bempedoic Acid & Commercialized (100% Indigenous)
31	Diethyl 2,2,14,14-tetramethyl-8-oxopentadecanedioate	738606-43-4	BEM-2	Advanced Intermediate for Bempedoic Acid & Commercialized (100% Indigenous)
32	2,2,14,14-tetramethyl-8-oxopentadecanedioic acid	413624-71-2	BEM-3	Advanced Intermediate for Bempedoic Acid & Commercialized (100% Indigenous)

Products

Our Philosophy

Manufacturing Site Location